$3.16 Billion is the total value of Rock Springs Capital Management LP's 130 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 23.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | $173,742,000 | +35.3% | 591,000 | 0.0% | 5.49% | +7.2% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $137,372,000 | +23.7% | 1,278,000 | +3.7% | 4.34% | -1.9% |
| WCG | WELLCARE HEALTH PLANS INC | $105,832,000 | +27.4% | 320,500 | 0.0% | 3.34% | +1.0% | |
| AMRN | AMARIN CORP PLCspons adr new | $99,696,000 | +41.4% | 4,650,000 | 0.0% | 3.15% | +12.1% | |
| ISRG | INTUITIVE SURGICAL INC | $90,150,000 | +9.5% | 152,500 | 0.0% | 2.85% | -13.2% | |
| JNJ | Buy | JOHNSON & JOHNSON | $81,323,000 | +1022.5% | 557,500 | +895.5% | 2.57% | +788.9% |
| HCA | HCA HEALTHCARE INC | $69,101,000 | +22.7% | 467,500 | 0.0% | 2.18% | -2.7% | |
| HUM | New | HUMANA INC | $67,806,000 | – | 185,000 | +100.0% | 2.14% | – |
| EHC | ENCOMPASS HEALTH CORP | $56,455,000 | +9.5% | 815,000 | 0.0% | 1.78% | -13.2% | |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $54,264,000 | +37.5% | 1,200,000 | +23.7% | 1.72% | +9.0% |
| PCRX | PACIRA BIOSCIENCES | $52,095,000 | +19.0% | 1,150,000 | 0.0% | 1.65% | -5.7% | |
| EPZM | Buy | EPIZYME INC | $50,430,000 | +164.3% | 2,050,000 | +10.8% | 1.59% | +109.6% |
| TFX | TELEFLEX INC | $48,937,000 | +10.8% | 130,000 | 0.0% | 1.55% | -12.2% | |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $44,583,000 | +75.4% | 345,500 | +2.4% | 1.41% | +39.1% |
| PODD | INSULET CORP | $44,598,000 | +3.8% | 260,500 | 0.0% | 1.41% | -17.7% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $44,447,000 | +29.2% | 203,000 | 0.0% | 1.40% | +2.5% | |
| BAX | Buy | BAXTER INTL INC | $43,901,000 | +30.4% | 525,000 | +36.4% | 1.39% | +3.4% |
| EW | EDWARDS LIFESCIENCES CORP | $42,809,000 | +6.1% | 183,500 | 0.0% | 1.35% | -15.9% | |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $42,488,000 | +3.3% | 624,000 | +12.4% | 1.34% | -18.1% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $41,922,000 | +57.7% | 364,000 | +10.1% | 1.32% | +25.1% |
| PEN | PENUMBRA INC | $39,835,000 | +22.1% | 242,500 | 0.0% | 1.26% | -3.2% | |
| ARGX | Buy | ARGENX SEsponsored adr | $39,729,000 | +91.9% | 247,500 | +36.2% | 1.26% | +52.1% |
| EXAS | Sell | EXACT SCIENCES CORP | $38,842,000 | -0.4% | 420,000 | -2.7% | 1.23% | -21.1% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $38,658,000 | +92.7% | 300,000 | +16.5% | 1.22% | +52.8% |
| ARDX | Buy | ARDELYX INC | $36,399,000 | +153.5% | 4,850,000 | +58.7% | 1.15% | +101.0% |
| GLPG | GALAPAGOS NVspon adr | $36,195,000 | +35.5% | 175,000 | 0.0% | 1.14% | +7.4% | |
| BGNE | BEIGENE LTDsponsored adr | $35,605,000 | +35.4% | 214,800 | 0.0% | 1.12% | +7.3% | |
| RARX | Sell | RA PHARMACEUTICALS INC | $35,198,000 | +78.2% | 750,000 | -10.2% | 1.11% | +41.3% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $35,110,000 | -7.8% | 1,950,000 | +3.7% | 1.11% | -26.9% |
| APRE | New | APREA THERAPEUTICS INC | $33,224,000 | – | 723,991 | +100.0% | 1.05% | – |
| NVRO | Buy | NEVRO CORP | $32,794,000 | +57.3% | 279,000 | +15.1% | 1.04% | +24.7% |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $32,414,000 | +78.9% | 1,575,000 | -0.2% | 1.02% | +41.8% |
| ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $32,390,000 | -19.2% | 975,000 | -24.4% | 1.02% | -36.0% |
| IDXX | IDEXX LABS INC | $31,388,000 | -4.0% | 120,200 | 0.0% | 0.99% | -23.8% | |
| ALGN | ALIGN TECHNOLOGY INC | $30,946,000 | +54.2% | 110,900 | 0.0% | 0.98% | +22.4% | |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $30,690,000 | +140.2% | 1,500,000 | +15.4% | 0.97% | +90.6% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $30,632,000 | +168.2% | 641,500 | +82.0% | 0.97% | +112.7% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $30,602,000 | +24.9% | 382,000 | +14.5% | 0.97% | -0.9% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $30,527,000 | +284.1% | 1,245,000 | +57.6% | 0.96% | +204.4% |
| AXNX | Buy | AXONICS MODULATION TECH INC | $30,481,000 | +459.2% | 1,100,000 | +443.2% | 0.96% | +343.8% |
| AMGN | AMGEN INC | $30,375,000 | +24.6% | 126,000 | 0.0% | 0.96% | -1.2% | |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $29,897,000 | +14.9% | 700,000 | +15.1% | 0.94% | -8.8% |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $29,702,000 | +44.4% | 213,500 | 0.0% | 0.94% | +14.5% | |
| QURE | Buy | UNIQURE NV | $28,664,000 | +274.4% | 400,000 | +105.7% | 0.91% | +197.0% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $28,663,000 | +325.9% | 670,000 | +258.3% | 0.91% | +238.1% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $28,536,000 | +197.1% | 337,500 | +136.8% | 0.90% | +135.5% |
| SGEN | SEATTLE GENETICS INC | $27,651,000 | +33.8% | 242,000 | 0.0% | 0.87% | +6.1% | |
| TMO | THERMO FISHER SCIENTIFIC INC | $26,314,000 | +11.5% | 81,000 | 0.0% | 0.83% | -11.6% | |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $26,258,000 | +209.5% | 421,890 | +68.8% | 0.83% | +145.6% |
| MDCO | Sell | MEDICINES CO | $26,136,000 | -34.7% | 307,699 | -61.5% | 0.83% | -48.2% |
| ZLAB | Buy | ZAI LAB LTDadr | $25,994,000 | +39.7% | 625,000 | +8.7% | 0.82% | +10.8% |
| BOLD | AUDENTES THERAPEUTICS INC | $24,534,000 | +113.0% | 410,000 | 0.0% | 0.78% | +68.8% | |
| WST | WEST PHARMACEUTICAL SVSC INC | $22,925,000 | +6.0% | 152,500 | 0.0% | 0.72% | -16.0% | |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $22,796,000 | -2.9% | 250,200 | -8.1% | 0.72% | -23.1% |
| ALLK | Sell | ALLAKOS INC | $22,410,000 | -1.7% | 235,000 | -19.0% | 0.71% | -22.1% |
| ACHN | Sell | ACHILLION PHARMACEUTICALS IN | $22,221,000 | +61.4% | 3,685,000 | -3.7% | 0.70% | +27.9% |
| INCY | Sell | INCYTE CORP | $21,830,000 | -5.8% | 250,000 | -19.9% | 0.69% | -25.3% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $21,492,000 | -23.7% | 900,000 | -14.3% | 0.68% | -39.5% |
| IMMU | Buy | IMMUNOMEDICS INC | $21,160,000 | +78.3% | 1,000,000 | +11.7% | 0.67% | +41.4% |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $21,065,000 | +63.8% | 265,000 | 0.0% | 0.67% | +30.1% | |
| FRPT | FRESHPET INC | $20,992,000 | +18.7% | 355,250 | 0.0% | 0.66% | -6.0% | |
| RDUS | Sell | RADIUS HEALTH INC | $20,164,000 | -39.8% | 1,000,200 | -23.1% | 0.64% | -52.2% |
| XENT | Sell | INTERSECT ENT INC | $19,920,000 | +34.2% | 800,000 | -8.3% | 0.63% | +6.4% |
| NVTA | Buy | INVITAE CORP | $19,356,000 | -10.7% | 1,200,000 | +6.7% | 0.61% | -29.2% |
| INSM | Sell | INSMED INC | $19,104,000 | +21.7% | 800,000 | -10.1% | 0.60% | -3.5% |
| FTSV | New | FORTY SEVEN INC | $17,717,000 | – | 450,000 | +100.0% | 0.56% | – |
| TBPH | Buy | THERAVANCE BIOPHARMA INC | $16,963,000 | +58.3% | 655,200 | +19.1% | 0.54% | +25.5% |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $16,306,000 | -3.2% | 545,000 | 0.0% | 0.52% | -23.2% | |
| CI | Sell | CIGNA CORP NEW | $15,337,000 | -53.4% | 75,000 | -65.4% | 0.48% | -63.0% |
| HQY | New | HEALTHEQUITY INC | $15,184,000 | – | 205,000 | +100.0% | 0.48% | – |
| OSW | New | ONESPAWORLD HOLDINGS LIMITED | $15,156,000 | – | 900,000 | +100.0% | 0.48% | – |
| PHR | Buy | PHREESIA INC | $15,052,000 | +72.0% | 565,000 | +56.5% | 0.48% | +36.4% |
| GH | GUARDANT HEALTH INC | $14,847,000 | +22.4% | 190,000 | 0.0% | 0.47% | -2.9% | |
| NVCR | NOVOCURE LTD | $14,537,000 | +12.7% | 172,500 | 0.0% | 0.46% | -10.7% | |
| CNC | CENTENE CORP DEL | $14,448,000 | +45.3% | 229,800 | 0.0% | 0.46% | +15.2% | |
| ODT | ODONATE THERAPEUTICS INC | $13,954,000 | +24.7% | 430,000 | 0.0% | 0.44% | -1.1% | |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $13,561,000 | +130.6% | 180,000 | -50.1% | 0.43% | +82.9% |
| FGEN | FIBROGEN INC | $13,124,000 | +16.0% | 306,000 | 0.0% | 0.42% | -8.0% | |
| ZGNX | ZOGENIX INC | $13,033,000 | +30.2% | 250,000 | 0.0% | 0.41% | +3.3% | |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $11,766,000 | +49.8% | 5,497,900 | +30.9% | 0.37% | +18.8% |
| MYOK | New | MYOKARDIA INC | $11,662,000 | – | 160,000 | +100.0% | 0.37% | – |
| CNST | New | CONSTELLATION PHARMCETICLS I | $11,000,000 | – | 233,500 | +100.0% | 0.35% | – |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $10,888,000 | -24.0% | 200,000 | -41.8% | 0.34% | -39.8% |
| ARVN | Buy | ARVINAS INC | $10,273,000 | +217.8% | 250,000 | +66.7% | 0.32% | +151.9% |
| DERM | Sell | DERMIRA INC | $9,854,000 | +99.0% | 650,000 | -16.1% | 0.31% | +57.9% |
| FOLD | AMICUS THERAPEUTICS INC | $9,740,000 | +21.4% | 1,000,000 | 0.0% | 0.31% | -3.8% | |
| BMY | New | BRISTOL MYERS SQUIBB CO | $9,629,000 | – | 150,000 | +100.0% | 0.30% | – |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $9,009,000 | +36.2% | 1,575,000 | -14.9% | 0.28% | +8.0% |
| FIXX | HOMOLOGY MEDICINES INC | $8,798,000 | +14.4% | 425,000 | 0.0% | 0.28% | -9.4% | |
| MEDICINES COnote 2.750% 7/1 | $8,735,000 | +44.4% | 5,000,000 | 0.0% | 0.28% | +14.5% | ||
| RTRX | Sell | RETROPHIN INC | $8,165,000 | -25.8% | 575,000 | -39.5% | 0.26% | -41.2% |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $7,921,000 | +20.3% | 345,000 | +13.1% | 0.25% | -4.6% |
| MNTA | MOMENTA PHARMACEUTICALS INC | $7,892,000 | +52.2% | 400,000 | 0.0% | 0.25% | +20.3% | |
| MYOV | Buy | MYOVANT SCIENCES LTD | $7,760,000 | +231.6% | 500,000 | +11.1% | 0.24% | +163.4% |
| TBIO | Sell | TRANSLATE BIO INC | $7,733,000 | -23.9% | 950,000 | -7.3% | 0.24% | -39.8% |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $7,065,000 | +219.4% | 1,233,000 | -11.9% | 0.22% | +153.4% |
| PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $6,874,000 | +16.4% | 1,125,000 | -20.6% | 0.22% | -7.7% |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $6,741,000 | +86.7% | 54,400 | 0.0% | 0.21% | +47.9% | |
| GRTX | New | GALERA THERAPEUTICS INC | $6,580,000 | – | 500,000 | +100.0% | 0.21% | – |
| CGEN | COMPUGEN LTDord | $6,556,000 | +40.9% | 1,100,000 | 0.0% | 0.21% | +11.9% | |
| NGM | NGM BIOPHARMACEUTICALS INC | $6,492,000 | +33.5% | 351,100 | 0.0% | 0.20% | +5.7% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $6,112,000 | -0.7% | 800,000 | 0.0% | 0.19% | -21.2% | |
| INSMED INCnote 1.750% 1/1 | $5,795,000 | +15.2% | 6,000,000 | 0.0% | 0.18% | -8.5% | ||
| CHMA | Buy | CHIASMA INC | $5,754,000 | +29.2% | 1,160,000 | +28.9% | 0.18% | +2.2% |
| HCAT | Buy | HEALTH CATALYST INC | $5,552,000 | +40.4% | 160,000 | +28.0% | 0.18% | +10.8% |
| TXG | Buy | 10X GENOMICS INC | $5,528,000 | +72.8% | 72,500 | +14.2% | 0.18% | +36.7% |
| RTIX | RTI SURGICAL HOLDINGS INC | $5,343,000 | -3.9% | 1,950,000 | 0.0% | 0.17% | -23.5% | |
| SPRO | SPERO THERAPEUTICS INC | $5,048,000 | -9.3% | 525,000 | 0.0% | 0.16% | -28.4% | |
| AKRO | AKERO THERAPEUTICS INC | $4,994,000 | -2.4% | 225,000 | 0.0% | 0.16% | -22.5% | |
| CO | GLOBAL CORD BLOOD CORPORATIO | $4,625,000 | +3.3% | 925,000 | 0.0% | 0.15% | -18.0% | |
| GMDA | GAMIDA CELL LTD | $4,300,000 | -0.7% | 1,000,000 | 0.0% | 0.14% | -21.4% | |
| BLUE | Sell | BLUEBIRD BIO INC | $3,071,000 | -28.8% | 35,000 | -25.5% | 0.10% | -43.6% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $3,024,000 | -5.9% | 1,600,000 | -46.2% | 0.10% | -25.0% |
| OBSV | Sell | OBSEVA SA | $3,016,000 | -73.4% | 789,480 | -42.0% | 0.10% | -78.9% |
| Sell | NABRIVA THERAPEUTICS PLC | $2,772,000 | -39.7% | 2,100,000 | -8.7% | 0.09% | -51.9% | |
| MGNX | Sell | MACROGENICS INC | $2,502,000 | -34.6% | 230,000 | -23.3% | 0.08% | -48.4% |
| ANAB | Sell | ANAPTYSBIO INC | $2,194,000 | -73.9% | 135,000 | -43.8% | 0.07% | -79.4% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $1,836,000 | -38.9% | 400,000 | -48.4% | 0.06% | -51.7% |
| THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $1,557,000 | +13.2% | 1,500,000 | 0.0% | 0.05% | -10.9% | ||
| NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,536,000 | +12.0% | 1,000,000 | 0.0% | 0.05% | -10.9% | ||
| PRTK | Sell | PARATEK PHARMACEUTICALS INC | $1,511,000 | -22.3% | 375,000 | -16.7% | 0.05% | -37.7% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $1,274,000 | -6.8% | 1,500,000 | 0.0% | 0.04% | -25.9% | ||
| PACIRA BIOSCIENCESnote 2.375% 4/0 | $1,042,000 | +5.5% | 1,000,000 | 0.0% | 0.03% | -15.4% | ||
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $960,000 | -27.3% | 800,000 | -8.6% | 0.03% | -43.4% |
| DERMIRA INCnote 3.000% 5/1 | $925,000 | +9.6% | 1,000,000 | 0.0% | 0.03% | -14.7% | ||
| CRVS | Sell | CORVUS PHARMACEUTICALS INC | $816,000 | -32.2% | 150,000 | -62.5% | 0.03% | -45.8% |
| BMYRT | New | BRISTOL MYERS SQUIBB COright 99/99/9999 | $557,000 | – | 185,150 | +100.0% | 0.02% | – |
| APLT | New | APPLIED THERAPEUTICS INC | $554,000 | – | 20,315 | +100.0% | 0.02% | – |
| PFE | New | PFIZER INC | $407,000 | – | 10,400 | +100.0% | 0.01% | – |
| CVET | COVETRUS INC | $273,000 | +11.0% | 20,683 | 0.0% | 0.01% | -10.0% | |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS IN | $0 | – | -400,000 | -100.0% | -0.01% | – |
| KLDO | Exit | KALEIDO BIOSCIENCES INC | $0 | – | -100,050 | -100.0% | -0.03% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -162,500 | -100.0% | -0.03% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -256,000 | -100.0% | -0.04% | – |
| CORV | Exit | CORREVIO PHARMA CORP | $0 | – | -1,200,000 | -100.0% | -0.10% | – |
| TORC | Exit | RESTORBIO INC | $0 | – | -400,000 | -100.0% | -0.14% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -425,000 | -100.0% | -0.15% | – |
| Exit | MEDICINES COnote 2.500% 1/1 | $0 | – | -3,000,000 | -100.0% | -0.18% | – | |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -900,000 | -100.0% | -0.18% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -587,400 | -100.0% | -0.25% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -27,000 | -100.0% | -0.26% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -122,500 | -100.0% | -0.41% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -95,000 | -100.0% | -0.44% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -92,500 | -100.0% | -0.52% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -185,150 | -100.0% | -0.73% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -214,500 | -100.0% | -0.94% | – |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -1,300,000 | -100.0% | -0.98% | – |
| SYK | Exit | STRYKER CORP | $0 | – | -179,000 | -100.0% | -1.54% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -525,000 | -100.0% | -1.58% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -505,371 | -100.0% | -1.95% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.